Kenneth D. Paull - Concepedia

Author

Kenneth D. Paull

National Cancer Institute

Also Known As

K D Paull, K Paull, K. D. PAULL, K. D. Paull, K. Paull, K.D. Paull, KD Paull, Kenneth D. Paull, Kenneth Paull

Publications

14.4K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Frederick National Laboratory for Cancer Research Fred Hutch Cancer Center Arizona State University

About

Kenneth D. Paull is an author at National Cancer Institute specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	31	6.4K
2	Biochemistry	14	15	3.5K
3	Natural Sciences	13	14	3.2K
4	Engineering	5	5	587
5	Health Sciences	3	3	319

Kenneth D. Paull

Publications

14.2K

Citations

H-Index

Page 1

	Year	Citations
Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines Anne Monks, Dominic A. Scudiero, Philip Skehan, JNCI Journal of the National Cancer Institute	1991	3.2K
Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Dominic A. Scudiero, Robert H. Shoemaker, Kenneth D. Paull, PubMed Chemoprevention StrategyPathologyCell CultureMetronomic ChemotherapyCell Growth	1988	2.4K
Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen Michael R. Boyd, Kenneth D. Paull Drug Development Research Chemoprevention StrategyCancer BiologyUnited StatesTumor BiologyPre-clinical Pharmacology	1995	1.5K
An Information-Intensive Approach to the Molecular Pharmacology of Cancer John N. Weinstein, Timothy G. Myers, P M O'Connor, Science	1997	1.2K
Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm Kenneth D. Paull, Robert H. Shoemaker, Louis Hodes, JNCI Journal of the National Cancer Institute	1989	960
Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines Larry Rubinstein, Robert H. Shoemaker, Kenneth D. Paull, JNCI Journal of the National Cancer Institute	1990	927
Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data Ruo Li Bai, Kenneth D. Paull, Cherry L. Herald, Journal of Biological Chemistry Vinca AlkaloidsBiochemistryVinca DomainMedicineMarine Natural Products	1991	375
Neural Computing in Cancer Drug Development: Predicting Mechanism of Action John N. Weinstein, Kurt W. Kohn, Michael R. Grever, Science EngineeringMachine LearningNeural ComputingScreening ProgramComputational Medicine	1992	310
Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4'-substituted phenyl)-4-quinolones and related compounds: identification as antimitotic agents interacting with tubulin Sheng Chu Kuo, Hong Zin Lee, Jung Pin Juang, Journal of Medicinal Chemistry	1993	195
Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data. Kenneth D. Paull, Chii M. Lin, Louis Malspeis, PubMed Pharmaceutical ScienceDrug TargetChemoprevention StrategyAntiparasitic AgentPharmaceutical Chemistry	1992	174

Page 1